Science is at the core of everything we do.

Benexia owns the first Novel Food authorization in Europe to commercialize chia oil — approved under Article 4 of Regulation (EC) 258/97, with a positive opinion from the Advisory Committee on Novel Foods and Processes; authorized uses include food supplements (2 g/day) and plant fats & oils (max 10%). Whole and ground chia seed and partially-defatted chia powder are separately authorized novel foods, now consolidated under Regulation (EU) 2015/2283.

In the EU, "Source of omega-3" requires ≥ 0.3 g ALA/100 g and "High in omega-3" ≥ 0.6 g ALA/100 g; the authorized health claim states that ALA contributes to the maintenance of normal blood cholesterol levels (2 g ALA/day).

In the United States, the FDA regulates chia as a food (not a food additive), and permits structure/function claims for heart, immune and skin/hair/nail health under standard conditions.

A "High in omega-3 ALA" content claim in the US generally requires ≥ 320 mg ALA per reference amount (RACC).